Is SZUKF or DVY a better dividend investment in 2026?

SZUKF currently yields 1.93% with a 5% 5-year dividend growth rate. DVY yields 3.46% with 5% growth. The better choice depends on your goal: DVY offers higher current income.

What is the dividend yield difference between SZUKF and DVY?

SZUKF has a forward dividend yield of 1.93% ($0.59/share annually). DVY yields 3.46% ($5.25/share annually). The yield gap is 1.53 percentage points.

Home › Compare › SZUKF vs DVY

SZUKF vs DVY: Dividend Comparison 2026

SZUKF yields 1.93% · DVY yields 3.46%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SZUKF wins by $6.2K in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

SZUKF

● Live price

1.93%

Share price

$30.30

Annual div

$0.59

5Y div CAGR

24%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.2K

Annual income

$2,432.69

Full SZUKF calculator →

DVY

● Live price

3.46%

Share price

$151.41

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.0K

Annual income

$432.91

Full DVY calculator →

Portfolio growth — SZUKF vs DVY

📍 SZUKF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SZUKF	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SZUKF + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SZUKF pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SZUKF

Annual income on $10K today (after 15% tax)

$164.32/yr

After 10yr DRIP, annual income (after tax)

$2,067.79/yr

DVY

Annual income on $10K today (after 15% tax)

$294.47/yr

After 10yr DRIP, annual income (after tax)

$367.97/yr

At 15% tax rate, SZUKF beats the other by $1,699.81/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SZUKF + DVY for your $10,000?

SZUKF: 50%DVY: 50%

100% DVY50/50100% SZUKF

Portfolio after 10yr

$28.1K

Annual income

$1,432.80/yr

Blended yield

5.09%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SZUKF right now

SZUKF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

2.7

Piotroski

4/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SZUKF buys

DVY buys

No recent congressional trades found for SZUKF or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSZUKFDVY

Forward yield	1.93%	3.46% ✓
Annual dividend / share	$0.59	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	24% ✓	0%
Portfolio after 10y	$31.2K ✓	$25.0K
Annual income after 10y	$2,432.69 ✓	$432.91
Total dividends collected	$9.6K ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SZUKF vs DVY ($10,000, DRIP)

Year	SZUKF Portfolio	SZUKF Income/yr	DVY Portfolio	DVY Income/yr	Gap
1	$10,940	$239.72	$11,046	$346.43	$106.00 → DVY
2	$12,009	$303.91	$12,177	$357.65	$168.00 → DVY
3	$13,237	$386.64	$13,398	$368.47	$161.00 → DVY
4	$14,657	$493.86	$14,715	$378.89	$58.00 → DVY
5← crossover	$16,317	$633.73	$16,134	$388.90	+$183.00 → SZUKF
6	$18,277	$817.58	$17,662	$398.51	+$615.00 → SZUKF
7	$20,617	$1,061.28	$19,306	$407.71	+$1.3K → SZUKF
8	$23,448	$1,387.40	$21,074	$416.50	+$2.4K → SZUKF
9	$26,918	$1,828.58	$22,974	$424.90	+$3.9K → SZUKF
10	$31,235	$2,432.69	$25,015	$432.91	+$6.2K → SZUKF

SZUKF vs DVY: Complete Analysis 2026

SZUKF — Stock

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Full SZUKF Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this SZUKF vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SZUKF vs SCHD SZUKF vs JEPI SZUKF vs O SZUKF vs KO SZUKF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.